MedPath
HSA Approval

TELSTAN-H 80/25 TABLET 80MG/25MG

SIN15091P

TELSTAN-H 80/25 TABLET 80MG/25MG

TELSTAN-H 80/25 TABLET 80MG/25MG

September 28, 2016

THINQ PHARMA - CRO PRIVATE LIMITED

THINQ PHARMA - CRO PRIVATE LIMITED

Regulatory Information

THINQ PHARMA - CRO PRIVATE LIMITED

THINQ PHARMA - CRO PRIVATE LIMITED

Therapeutic

Prescription Only

Formulation Information

TABLET

ORAL

Medical Information

C09DA07

telmisartan and diuretics

Manufacturer Information

THINQ PHARMA - CRO PRIVATE LIMITED

Alembic Pharmaceuticals Limited (Formulation Division)

Active Ingredients

Hydrochlorothiazide

25.00 mg/tablet

Hydrochlorothiazide

Telmisartan

80.00 mg/tablet

Telmisartan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TELSTAN-H 80/25 TABLET 80MG/25MG - HSA Approval | MedPath